G Derigs
Overview
Explore the profile of G Derigs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kroger N, Damon L, Zander A, Wandt H, Derigs G, Ferrante P, et al.
Bone Marrow Transplant
. 2003 Dec;
32(12):1153-7.
PMID: 14647269
The incidence of secondary myelodysplasia/acute myeloid leukemia (AML) was retrospectively assessed in an international joint study in 305 node-positive breast cancer patients, who received mitoxantrone-based high-dose chemotherapy (HDCT) followed by...
2.
Rick O, Bokemeyer C, Beyer J, Hartmann J, Schwella N, Kingreen D, et al.
J Clin Oncol
. 2001 Jan;
19(1):81-8.
PMID: 11134198
Purpose: To study feasibility and efficacy of a new salvage regimen in patients with relapsed and/or refractory germ cell tumors. Patients And Methods: Between May 1995 and February 1997, 80...
3.
Craddock C, Bardy P, Kreiter S, Johnston R, Apperley J, Marks D, et al.
Br J Haematol
. 2000 Dec;
111(3):797-800.
PMID: 11122140
Graft-versus-host disease (GVHD) remains a significant complication in patients undergoing allogeneic stem cell transplantation (SCT) using a reduced intensity conditioning regimen. Although T-cell depletion (TCD) reduces the risk of GVHD...
4.
Bokemeyer C, Hartmann J, Mayer F, Bohlke I, Kanz L, von Pawel J, et al.
Oncology (Williston Park)
. 2000 Dec;
14(10 Suppl 9):63-7.
PMID: 11098497
The palliation of symptoms and improvement of quality of life are important aspects of therapy in patients with incurable metastatic cancer. This article describes the preliminary results of a phase...
5.
Kollmannsberger C, Nichols C, Bamberg M, Hartmann J, Schleucher N, Beyer J, et al.
Ann Oncol
. 2000 Jul;
11(5):553-9.
PMID: 10907948
Purpose: To examine the feasibility and efficacy of first-line high-dose chemotherapy (HD-CTX) in patients with advanced metastatic germ-cell tumors (GCT) and brain metastases. Patients And Methods: Twenty-two patients with brain...
6.
Fischer T, Neubauer A, Mohm J, Huhn D, Busemann C, Link H, et al.
Ann Hematol
. 1998 Oct;
77(1-2):21-6.
PMID: 9760148
High-dose chemotherapy with autologous transplantation of in vivo purged PBSC is a novel investigational approach to treating chronic myelogenous leukemia (CML) patients not responsive to conventional therapy with interferon-alpha (IFN-alpha)...
7.
Oberholzer K, Kauczor H, Heussel C, Derigs G, Thelen M
Rofo
. 1997 Jun;
166(6):493-7.
PMID: 9273000
Purpose: To investigate the clinical necessity of CT of the paranasal sinuses before bone marrow or peripheral blood stem cell transplantation. Patients And Methods: 80 patients with malignant disease underwent...
8.
Schwab R, Peschel C, Despres D, Derigs G, Fischer T, Huber C, et al.
Cytokines Mol Ther
. 1995 Dec;
1(4):281-8.
PMID: 9384681
Cell cycle control subsequent to gamma irradiation or growth factor starvation has been studied in immative hematopoietic cells of 19 previously untreated chronic myeloid leukemia (CML) patients in chronic phase...
9.
Aman M, Keller U, Derigs G, Mohamadzadeh M, Huber C, Peschel C
Blood
. 1994 Dec;
84(12):4142-50.
PMID: 7994029
We investigated the effects of interferon-alpha (IFN-alpha) on the expression of cytokines by human bone marrow stromal cells. Production of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte-CSF (G-CSF), and interleukin-1 beta (IL-1...
10.
Keller U, Aman M, Derigs G, Huber C, Peschel C
Blood
. 1994 Oct;
84(7):2189-96.
PMID: 7522623
Interleukin-4 (IL-4) has distinct hematopoietic activities, primarily as a costimulant with other cytokines to enhance colony formation of hematopoietic progenitors. We investigated the influence of IL-4 on stromal cell-supported long-term...